Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma
The objective of the present study was to evaluate the efficacy and safety of regorafenib in comparison with dinutuximab with chemotherapy in Chinese children with advanced neuroblastoma. The patients aged less than 16 years who were histologically diagnosed with advanced neuroblastoma were enrolled...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bangladesh Pharmacological Society
2019-02-01
|
| סדרה: | Bangladesh Journal of Pharmacology |
| נושאים: | |
| גישה מקוונת: | https://www.bjp.asia/index.php/bjp/article/view/8 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|